Severity
Moderate
FDA Drug recall · Reported October 25, 2023
CGMP Deviations: OTC products were stored outside of labeled temperature requirements.
Dollar Tree Distribution, Inc. recalled Certain Over-The-Counter (OTC) drug products sold by Family Dollar retail stores. - a moderate-severity action.
Certain Over-The-Counter (OTC) drug products sold by Family Dollar retail stores. was recalled by Dollar Tree Distribution, Inc. in October 25, 2023. Reason: CGMP Deviations: OTC products were stored outside of labeled temperature requirements.. Check the official notice for the remedy. Verify recall #D-0045-2024 with the FDA Drug before acting.
The recall
Dollar Tree Distribution, Inc. issued this moderate-severity FDA Drug recall-CGMP Deviations: OTC products were stored outside of labeled temperature requirements..
Sourced from official FDA Drug enforcement records. Verify recall #D-0045-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0045-2024) was formally reported on October 25, 2023, with the manufacturer initiating the action on October 5, 2023. It is classified under Moderate severity (Class II), with a current status of Ongoing. Dollar Tree Distribution, Inc. is listed as the recalling firm, operating out of Chesapeake, VA. Federal records list the affected scope as 4,261,383 units of various products.
The documented reason for this recall is: CGMP Deviations: OTC products were stored outside of labeled temperature requirements. Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
4,261,383 units of various products
Related Recalls
6
5 from same agency
Certain Over-The-Counter (OTC) drug products sold by Family Dollar retail stores.
CGMP Deviations: OTC products were stored outside of labeled temperature requirements.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0045-2024 |
| Date reported | October 25, 2023 |
| Date initiated | October 5, 2023 |
| Recalling firm | Dollar Tree Distribution, Inc. |
| Firm location | Chesapeake, VA |
| Affected scope | 4,261,383 units of various products |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 25, 2023. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.